Statistics for Deferoxamine, deferasirox, and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a randomised clinical trial

Total visits

views
Deferoxamine, deferasirox, and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a randomised clinical trial 0

Total visits per month

views
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 0

File Visits

views
Deferoxamine,deferasirox, anddeferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload- a randomised clinical trial.pdf 4